Skip to main content

Table 3 Univariate analysis of oxygen use and potential confounders for survival

From: Oxygen use and survival in patients with advanced cancer and low oxygen saturation in home care: a preliminary retrospective cohort study

 

Death

Death at home

Unadjusted HR (95% CI)

p-value

Unadjusted HR (95% CI)

p-value

Oxygen use

0.59 (0.39–0.88)

0.011

0.58 (0.36–0.92)

0.021

Age

0.99 (0.97–1.00)

0.16

0.99 (0.98–1.01)

0.50

Sex, male

1.33 (0.93–1.91)

0.12

1.25 (0.83–1.89)

0.28

Systolic blood pressure

0.99 (0.98–1.00)

0.008

0.98 (0.97–0.99)

0.002

Heart rate

1.00 (0.99–1.01)

0.94

1.01 (1.00–1.02)

0.24

Oxygen saturation

1.02 (0.98–1.06)

0.28

1.02 (0.98–1.07)

0.27

Decreased level of consciousness

2.26 (1.57–3.24)

<  0.001

2.81 (1.86–4.24)

<  0.001

Dyspnea

0.83 (0.57–1.20)

0.32

0.98 (0.64–1.49)

0.92

Edema

1.09 (0.76–1.55)

0.64

1.14 (0.76–1.71)

0.51

Oral intake

0.48 (0.36–0.62)

<  0.001

0.31 (0.22–0.43)

<  0.001

Performance status

1.68 (1.29–2.18)

<  0.001

2.14 (1.59–2.87)

<  0.001

Cardiopulmonary comorbidity

0.44 (0.25–0.80)

0.006

0.46 (0.23–0.91)

0.026

Lung cancer as primary tumor

0.76 (0.51–1.14)

0.18

0.73 (0.45–1.17)

0.19

  1. CI Confidence interval, HR Hazard ratio